SeaStar Medical Holding Corporation (ICU : NASDAQ)
Common Stock
Follow ICU
ICU
SeaStar Medical Holding Corporation
Performance
1 Day
+33.16%
1 Week
-45.83%
1 Month
-66.56%
YTD
-66.01%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$5.58M
52W High
$5.38
52W Low
$0.98
P/E Ratio
-
50 Day MA
$3.01
200 Day MA
$3.31
Beta
-1.04
Dividend Yield
-
Performance history
ICU returns since 2026
SeaStar Medical Holding Corporation has traded since Jun 2026 in our data. Its deepest fall was −84.6% (Jul 2026 to Nov 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*−66.0%
* Partial year (first year of data, or year to date).
$10,000 invested in ICU
- 2026 (start of our data)$3,399
- All-time high in our data
- $5 on Jul 8, 2026 · now −79.5%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past ICU? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/18/2026 | $0.83 | $1.07 | $0.76 | $1.04 | $1.04 | 683,262 |
| 11/17/2026 | $0.89 | $0.89 | $0.78 | $0.78 | $0.78 | 142,880 |
| 11/16/2026 | $0.80 | $0.86 | $0.79 | $0.85 | $0.85 | 183,485 |
| 11/13/2026 | $1.08 | $1.08 | $0.81 | $0.84 | $0.84 | 598,700 |
| 11/12/2026 | $1.21 | $1.31 | $0.98 | $1.05 | $1.05 | 798,842 |
| 11/11/2026 | $1.89 | $2.00 | $1.85 | $1.92 | $1.92 | 141,834 |
| 11/10/2026 | $1.96 | $1.97 | $1.90 | $1.90 | $1.90 | 36,193 |
| 11/9/2026 | $1.92 | $2.00 | $1.84 | $1.96 | $1.96 | 140,987 |
| 11/6/2026 | $1.93 | $1.99 | $1.88 | $1.88 | $1.88 | 58,400 |
| 11/5/2026 | $2.04 | $2.06 | $1.89 | $1.92 | $1.92 | 84,889 |
Analyst Price Targets
Based on 1 analyst covering ICU · as of Sep 17, 2026
Wall Street analysts forecast ICU stock price to rise 861.5% over the next 12 months.
Consensus
Buy4.00 / 5.00
Avg. Target
US$10.00
+861.5% Upside
Current Price
US$1.04
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ICU's historical volatility
30-Day Vol
222.4%
Annualized
90-Day Vol
157.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.87
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.98 | US$0.45 – US$2.11 |
| 60 trading days | US$0.92 | US$0.31 – US$2.73 |
| 90 trading days | US$0.87 | US$0.23 – US$3.29 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Financials
- Revenue (TTM)
- $1.71M
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- -356.87%
- EPS (Diluted)
- -2.97
- Book Value
- 1.01
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About ICU.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SKYA | SkyAI, Inc. | $4.13 | +90.32% |
| CUE | Cue Biopharma | $4.76 | +68.20% |
| CLRO | ClearOne Inc | $6.90 | +46.19% |
| AZI | Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares | $1.04 | +42.45% |
| NUR | Nuran Wireless Inc. Common Shares | $0.50 | +33.76% |
| ANPA | Rich Sparkle Holdings Limited Ordinary Shares | $1.40 | +33.33% |
| HIHO | Highway Holdings Limited | $1.61 | +30.89% |
| HPAI | Helport AI Limited Ordinary Shares | $0.26 | +27.23% |
Free with a Wealth Awesome account
Keep analysing ICU, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
